MEDICAL MYCOLOGY
Scope & Guideline
Illuminating the Pathways of Fungal Pathogenesis
Introduction
Aims and Scopes
- Fungal Pathogenesis and Host Interaction:
Research on the mechanisms by which fungi cause disease, including their interactions with the host immune system, cellular responses, and virulence factors. - Epidemiology of Fungal Infections:
Investigating the distribution, determinants, and dynamics of fungal infections globally, with a focus on emerging and re-emerging pathogens. - Antifungal Resistance and Drug Development:
Studies addressing the mechanisms of antifungal resistance, susceptibility testing, and the development of new antifungal agents and therapeutic strategies. - Clinical Management of Fungal Diseases:
Research on clinical outcomes, treatment options, and management strategies for various fungal infections, including case studies and large cohort analyses. - Diagnostic Innovations:
Advancements in diagnostic techniques for fungal infections, including molecular methods, serological tests, and the development of rapid diagnostic tools. - Mycology in Animal Health:
Exploration of fungal diseases affecting animals, their zoonotic potential, and the implications for public health. - Environmental Mycology:
Research on the role of environmental fungi in human health, including their implications in allergies, asthma, and other respiratory diseases.
Trending and Emerging
- COVID-19-Associated Fungal Infections:
Research on the rise of fungal infections related to COVID-19, particularly mucormycosis and candidemia, has surged, highlighting the intersection of viral and fungal diseases. - Molecular Epidemiology and Genotyping:
There is a growing trend towards using molecular techniques for the epidemiological study of fungal pathogens, focusing on genetic diversity, strain typing, and tracking outbreaks. - Fungal Biofilms and Resistance Mechanisms:
An increasing number of studies are addressing the formation of biofilms by fungal pathogens and their implications for treatment resistance, particularly in candidiasis. - Novel Antifungal Compounds and Therapies:
Research into new antifungal agents, including novel compounds and combination therapies, is on the rise, reflecting the urgent need to combat resistant fungal strains. - Fungal Immunology and Vaccine Development:
Emerging interest in understanding host immune responses to fungal infections and the potential for vaccine development is becoming a prominent area of research. - Zoonotic Fungal Infections:
Research on zoonotic fungi and their implications for human health is gaining attention, particularly in the context of environmental changes and animal health.
Declining or Waning
- Traditional Antifungal Therapies:
There has been a noticeable shift towards exploring new antifungal compounds and strategies, leading to less emphasis on established therapies, such as polyenes and older azoles. - Basic Mycological Taxonomy:
Research focused solely on the taxonomy of fungi without direct clinical implications has decreased, as the journal increasingly prioritizes studies with direct relevance to human health. - Invasive Fungal Infections in Non-Immunocompromised Hosts:
The focus on invasive fungal infections in generally healthy individuals is waning, reflecting a growing emphasis on immunocompromised populations and patients with comorbidities. - Fungal Ecology without Clinical Context:
Studies exploring fungal ecology that do not connect findings to clinical outcomes or implications for health are becoming less common in the journal.
Similar Journals
Therapeutic Advances in Infectious Disease
Pioneering progress in infectious disease pharmacology.Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.
Mycosphere
Exploring the intricate connections of fungi and ecosystems.Mycosphere is a premier open-access journal published by MYCOSPHERE PRESS, dedicated to advancing the field of mycology and contributing significant insights into ecological and plant sciences. Established in 2010 and headquartered in Guiyang, China, this journal has carved out a vital niche, achieving remarkable rankings in the Scopus database—#3 in Ecology, Evolution, Behavior and Systematics and #4 in Plant Science, both boasting a 99th percentile ranking. With an unwavering commitment to disseminating high-quality research, Mycosphere serves as a critical platform for researchers, professionals, and students alike, encouraging robust dialogue and collaborations across the global scientific community. The journal's accessibility, coupled with its impact factor and Q1 categorizations in 2023 for both ecology and plant sciences, substantiate its role as an essential resource for cutting-edge studies and innovations in the field.
Journal of Fungi
Innovating Understanding in Fungal BiologyJournal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.
REVISTA IBEROAMERICANA DE MICOLOGIA
Elevating Knowledge in Fungal Studies and PathologyREVISTA IBEROAMERICANA DE MICOLOGIA, published by the ASOCIACION ESPANOLA MICOLOGIA-AEM, is a vital resource for those engaged in the study of mycology and infectious diseases. With a history spanning from 1996 to 2024, this journal is committed to advancing knowledge in the field through the dissemination of high-quality research articles, reviews, and case studies. Although it currently features a Q3 ranking in Infectious Diseases and a Q4 ranking in Microbiology for 2023, its impact is significant given the niche focus it serves, catering to a specialized audience of researchers and practitioners. While access is not open, the journal continues to be a preferred platform for scholarly communication among professionals in Spain and beyond. The editorial office, located in Bilbao, serves as the hub for rigorous peer-review and publication processes, ensuring that the latest advancements and findings in the field of mycology are effectively shared within the scientific community.
Fungal Biology Reviews
Synthesis and Insight in Fungal StudiesFungal Biology Reviews is a premier academic journal published by Elsevier Science Ltd, focusing on the rapidly evolving field of fungal biology. With an ISSN of 1749-4613 and an E-ISSN of 1878-0253, this journal has established itself as a leading resource for researchers, academics, and professionals dedicated to advancing our understanding of fungi and their ecological, agricultural, and medical implications. As a testament to its impact and quality, Fungal Biology Reviews holds a distinguished Q1 classification in both Microbiology and Plant Science categories for 2023, with a notable rank of 26 out of 182 in the Microbiology category. The journal uniquely blends comprehensive reviews that synthesize current research findings with forward-looking perspectives that pave the way for future studies, making it indispensable for anyone involved in fungal research. Although it operates under a traditional access model, its commitment to fostering impactful scholarship ensures that it remains relevant and widely cited within the academic community. Spanning from its inception in 2007 through to its projected conclusion in 2024, Fungal Biology Reviews continues to shape the framework for future discoveries in fungal biology.
Medical Mycology Journal
Illuminating the Path to Improved Fungal Infection OutcomesMedical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.
MYCOSCIENCE
Fostering Innovation in Mycological ResearchMYCOSCIENCE, published by the Mycological Society of Japan, is a prominent peer-reviewed journal that serves as an essential resource in the fields of ecology, evolution, behavior, and systematics, highlighted by its Q2 ranking in the 2023 category quartiles. Established in 1994 and continuing through 2024, the journal focuses on mycological research, providing insights into the interconnected worlds of fungi and their ecological roles. With an ISSN of 1340-3540 and an E-ISSN of 1618-2545, MYCOSCIENCE aims to disseminate high-quality research that addresses current issues and trends within the discipline. Despite not being an open-access journal, it makes a significant contribution to advancing fungal biology and its applications in agriculture and environmental science, making it an invaluable asset for researchers, professionals, and students alike. Located in the vibrant academic environment of Tokyo, Japan, MYCOSCIENCE stands out for its dedication to fostering a deeper understanding of mycology and its implications for biodiversity and ecosystem health.
MYCOPATHOLOGIA
Elevating research standards in mycology and plant health.MYCOPATHOLOGIA, published by Springer in the Netherlands, stands as a pivotal journal in the fields of mycology, plant science, and veterinary microbiology. With its extensive history dating back to 1938, this journal has consistently contributed to the understanding of fungal pathogens and their impact on both agriculture and animal health. It currently holds impressive rankings in Scopus, including Q1 status in Agronomy and Crop Science, and Q2 rankings in Applied Microbiology and Biotechnology, demonstrating its influence and rigor in the scientific community. Researchers and professionals benefit from its curated, high-quality studies which address critical areas such as plant-pathogen interactions and veterinary mycology. While not open access, MYCOPATHOLOGIA emphasizes comprehensive research output and serves as a vital resource for advancing knowledge and fostering innovation in its disciplines. The journal remains committed to disseminating valuable insights that drive forward both academic inquiry and practical applications in related fields, ensuring its relevance and importance in contemporary research.
MYCOBIOLOGY
Innovating Research Across Infectious Diseases and Plant ScienceMYCOBIOLOGY is an esteemed open-access journal published by Taylor & Francis Ltd, specializing in the fields of Infectious Diseases, Microbiology, and Plant Science. Since its inception, the journal has provided a platform for innovative research, showcasing a diverse range of studies that delve into the complexities of mycology and its vast implications on health, agriculture, and the environment. With a commendable impact factor and a Q2 ranking in Plant Science as of 2023, MYCOBIOLOGY facilitates the dissemination of vital findings to a global audience of researchers, professionals, and students. In addition to its commitment to high-quality content, MYCOBIOLOGY has embraced open access since 2018, ensuring that the latest advancements in mycological research are readily available to the academic community and the public. By bridging gaps in knowledge and fostering collaboration across disciplines, MYCOBIOLOGY plays a crucial role in advancing our understanding of fungal biology and its myriad applications.
FUNGAL DIVERSITY
Innovating Ecological Understanding Through Fungal ResearchFungal Diversity is a premier academic journal dedicated to advancing the science of mycology, encompassing ecological, evolutionary, and biological research involving fungi. Published by Springer, this journal has established a significant presence in the academic community since its inception in 1998, and it continues to thrive with a convergence period extending to 2024. Holding a prestigious Q1 ranking in several categories — including Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science — Fungal Diversity showcases cutting-edge research that influences ecological management, conservation, and biodiversity studies. With its notable positions in Scopus rankings, including being ranked #1 in Environmental Science - Ecology, the journal serves as an essential resource for researchers, professionals, and students interested in the complex interplay between fungi and their environments. Although it does not currently offer open access, interested readers can benefit from the journal's rich repository of peer-reviewed articles, making Fungal Diversity a vital component of the scientific literature landscape.